Drug Trial Radar · NCT00062699
Evaluate the Survival Benefits of Zemplar Versus Calcijex in Subjects w/ Stage V Chronic Kidney Disease on Hemodialysis
Last checked: Nov 19, 2026Latest source record: Aug 2, 2006 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
2,200
Actual
Start
Apr 2003
Primary completion
Not stated
Sponsor
- Lead sponsor
- AbbottIndustry
- Sponsor type
- Industry
- First posted
- Jun 13, 2003
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double
- Primary purpose
- Treatment
- Who can join
- All sexes, from 20 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To evaluate the survival benefit associated with Zemplar therapy as compared to Calcijex for the treatment of secondary hyperparathyroidism in subjects with Stage V chronic kidney disease on hemodialysis as measured by time to death.
Conditions
- End-Stage Kidney Disease
Interventions
Zemplar (paricalcitol injection)Drug
CalcijexDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to Death
Locations
60 sites in 1 country. Site status is shown where the registry gives one.
Tuscaloosa Nephrology Associates
Tuscaloosa, Alabama
Gambro Healthcare - Inglewood
Inglewood, California
Gambro Healthcare - Los Angeles
Los Angeles, California
Apex Research of Riverside
Riverside, California
East Bay Nephrology Medical Group
San Pablo, California
Nephrology Educational Services and Research, Inc.
Tarzana, California
Lowry DaVita Dialysis Unit
Denver, Colorado
Stamford Nephrology
Stamford, Connecticut
Capital Dialysis Unit
Washington D.C., District of Columbia
Capitol Dialysis
Washington D.C., District of Columbia
Dupont III, P.C.
Washington D.C., District of Columbia
Capital Dialysis Northwest
Washington D.C., District of Columbia
Renal Associates of Boca Raton
Boca Raton, Florida
Associates in Nephrology
Fort Myers, Florida
Orlando Nephrology
Winter Garden, Florida
Nephrology Associates, P.C.
Augusta, Georgia
Nephrology Center of America - Augusta
Augusta, Georgia
Nephrology Center of America - South Augusta
Augusta, Georgia
Nephrology Center of America - Grovetown
Grovetown, Georgia
Nephrology Center of America - Vidalia
Vidalia, Georgia
Northwestern University - Division of Nephrology
Chicago, Illinois
Renal Care Group
Chicago, Illinois
University of Chicago Medical Center
Chicago, Illinois
Evanston Northwestern Healthcare
Evanston, Illinois
Indiana University Hospital
Indianapolis, Indiana
Louisiana State University Health and Sciences Center
New Orleans, Louisiana
Tulane University Health Sciences Center
New Orleans, Louisiana
Uptown Dialysis Center
New Orleans, Louisiana
Northwest Louisiana Nephrology
Shreveport, Louisiana
Paul Light, University of Maryland
Baltimore, Maryland
Gambro Healthcare - Whitesquare Dialysis Center
Baltimore, Maryland
Gambo Healthcare - JB Zachary Dialysis Center
Baltimore, Maryland
Johns Hopkins University
Baltimore, Maryland
Gambro Healthcare - Dundalk Dialysis Center
Dundalk, Maryland
Kidney Center of Frederick
Frederick, Maryland
Joslin Diabetes Center
Boston, Massachusetts
Washington University School of Medicine
St Louis, Missouri
Nephrology Foundation of Brooklyn
Brooklyn, New York
Brookdale University Hospital and Medical Center
Brooklyn, New York
Nephrology Foundation of Brooklyn
Brooklyn, New York
Showing 40 of 60 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.